<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effect of 6 months combined, continuous hormone replacement therapy (HRT) with conjugated equine <z:chebi fb="67" ids="50114">oestrogen</z:chebi> (0.625 mg) and <z:chebi fb="0" ids="6716">medroxyprogesterone acetate</z:chebi> (2.5 mg) on albumin/<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio (ACR) was determined in postmenopausal diabetic women in a randomised, controlled study </plain></SENT>
<SENT sid="1" pm="."><plain>Mean (interquartile range) change in plasma ACR was not (P=0.96) different in women receiving HRT [2 (-11, 21) mg/g, n=20] compared with those randomised to placebo [2 (-1, 14) mg/g, n=27] </plain></SENT>
<SENT sid="2" pm="."><plain>Also, the proportion of women with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> did not change (P=0.75) during HRT (baseline, 0.45; end of study, 0.53) </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, several risk factors for <z:mp ids='MP_0002959'>microalbuminuria</z:mp> including systolic blood pressure (SBP), fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi>, glycated <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> (HbA1c) and <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> did not vary significantly during HRT </plain></SENT>
<SENT sid="4" pm="."><plain>These data suggest that 6 months HRT does not reverse <z:mp ids='MP_0002959'>microalbuminuria</z:mp> caused by prolonged <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> and other risk factors that underlie leakage of albumin into the urine in postmenopausal women with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>